Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the safety and tolerability of the elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (EVG/COBI/FTC/TAF; E/C/F/TAF) fixed dose combination (FDC) in HIV-1 infected adults with end stage renal disease (ESRD) on chronic hemodialysis (HD) at Week 48
Inclusion criteria
- Human Immunodeficiency Virus (HIV-1) Infection in Subjects on Chronic Hemodialysis